Journal article

Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis

Andrew J O'Brien, Linda A Villani, Lindsay A Broadfield, Vanessa P Houde, Sandra Galic, Giovanni Blandino, Bruce E Kemp, Theodoros Tsakiridis, Paola Muti, Gregory R Steinberg

Biochemical Journal | PORTLAND PRESS LTD | Published : 2015

Grants

Awarded by Canadian Institutes of Health Research


Awarded by Canadian Cancer Society


Awarded by Australian Research Council


Awarded by National Health and Medical Research Council


Funding Acknowledgements

This work was supported by the Canadian Institutes of Health Research [grant number MOP-11480 (to G.R.S. and T.T.)]; the Canadian Cancer Society [grant number P#20001191 (to G.R.S. and P.M.)]; the Australian Research Council [grant number DP130104548 (to G.R.S., B.E.K. and S.G.)]; the National Health and Medical Research Council [grant number APP1085460 (to G.R.S., B.E.K. and S.G.)]; and the Victorian Government's Operational Infrastructure Support Program.